OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent advances in microtubule-stabilizing agents
Yanan Cao, Lingli Zheng, Dan Wang, et al.
European Journal of Medicinal Chemistry (2017) Vol. 143, pp. 806-828
Closed Access | Times Cited: 152
Yanan Cao, Lingli Zheng, Dan Wang, et al.
European Journal of Medicinal Chemistry (2017) Vol. 143, pp. 806-828
Closed Access | Times Cited: 152
Showing 1-25 of 152 citing articles:
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 218
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 218
Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains
Fatima Naaz, Md Rafi Haider, Syed Shafi, et al.
European Journal of Medicinal Chemistry (2019) Vol. 171, pp. 310-331
Closed Access | Times Cited: 163
Fatima Naaz, Md Rafi Haider, Syed Shafi, et al.
European Journal of Medicinal Chemistry (2019) Vol. 171, pp. 310-331
Closed Access | Times Cited: 163
Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery
Duan Ni, Shaoyong Lu, Jian Zhang
Medicinal Research Reviews (2019) Vol. 39, Iss. 6, pp. 2314-2342
Closed Access | Times Cited: 89
Duan Ni, Shaoyong Lu, Jian Zhang
Medicinal Research Reviews (2019) Vol. 39, Iss. 6, pp. 2314-2342
Closed Access | Times Cited: 89
A novel synthetic microtubule inhibitor exerts antiproliferative effects in multidrug resistant cancer cells and cancer stem cells
Mi Na Park, Jee Won Hwang, Yena Cho, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 61
Mi Na Park, Jee Won Hwang, Yena Cho, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 61
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 60
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 60
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
Rui Qin, Feng‐Ming You, Qian Zhao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Rui Qin, Feng‐Ming You, Qian Zhao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Paclitaxel resistance related to nuclear envelope structural sturdiness
Elizabeth R. Smith, Jing‐Quan Wang, Dong‐Hua Yang, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100881-100881
Closed Access | Times Cited: 46
Elizabeth R. Smith, Jing‐Quan Wang, Dong‐Hua Yang, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100881-100881
Closed Access | Times Cited: 46
Hinokitiol functions as a ferroptosis inhibitor to confer neuroprotection
Junmin Xi, Zhijun Zhang, Zuo Wang, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 202-215
Closed Access | Times Cited: 37
Junmin Xi, Zhijun Zhang, Zuo Wang, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 202-215
Closed Access | Times Cited: 37
Articular fibrocartilage-targeted therapy by microtubule stabilization
Jiawei Li, Huiming Jiang, Zhongyang Lv, et al.
Science Advances (2022) Vol. 8, Iss. 46
Open Access | Times Cited: 36
Jiawei Li, Huiming Jiang, Zhongyang Lv, et al.
Science Advances (2022) Vol. 8, Iss. 46
Open Access | Times Cited: 36
Small molecules targeting protein–protein interactions for cancer therapy
Defa Wu, Yang Li, Lang Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4060-4088
Open Access | Times Cited: 31
Defa Wu, Yang Li, Lang Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4060-4088
Open Access | Times Cited: 31
A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms
András Nagy, Denise Börzsei, Alexandra Hoffmann, et al.
Cardiovascular Drugs and Therapy (2024)
Open Access | Times Cited: 8
András Nagy, Denise Börzsei, Alexandra Hoffmann, et al.
Cardiovascular Drugs and Therapy (2024)
Open Access | Times Cited: 8
Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance
Guimei Li, Meng Wang, Li Luo, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117249-117249
Closed Access
Guimei Li, Meng Wang, Li Luo, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117249-117249
Closed Access
A novel amino-pyrimidine inhibitor suppresses tumor growth via microtubule destabilization and Bmi-1 down-regulation
Lijie Gao, Jiawei Liu, Rui Zhang, et al.
Biochemical Pharmacology (2025), pp. 116783-116783
Closed Access
Lijie Gao, Jiawei Liu, Rui Zhang, et al.
Biochemical Pharmacology (2025), pp. 116783-116783
Closed Access
Pathological Changes of Tau Related to Alzheimer’s Disease
Dandan Chu, Fei Liu
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 2, pp. 931-944
Closed Access | Times Cited: 77
Dandan Chu, Fei Liu
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 2, pp. 931-944
Closed Access | Times Cited: 77
Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents
M. Shaheer Malik, Saleh A. Ahmed, Ismail Althagafi, et al.
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 3, pp. 327-348
Open Access | Times Cited: 62
M. Shaheer Malik, Saleh A. Ahmed, Ismail Althagafi, et al.
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 3, pp. 327-348
Open Access | Times Cited: 62
Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies
Sravani Sana, Velma Ganga Reddy, T. Srinivasa Reddy, et al.
Bioorganic Chemistry (2021) Vol. 110, pp. 104765-104765
Closed Access | Times Cited: 53
Sravani Sana, Velma Ganga Reddy, T. Srinivasa Reddy, et al.
Bioorganic Chemistry (2021) Vol. 110, pp. 104765-104765
Closed Access | Times Cited: 53
Mycotoxin toxicity and its alleviation strategy on female mammalian reproduction and fertility
Ping‐Shuang Lu, Shao‐Chen Sun
Journal of Advanced Research (2025)
Open Access
Ping‐Shuang Lu, Shao‐Chen Sun
Journal of Advanced Research (2025)
Open Access
Synthesis and Screening of Novel 2,4-Bis Substituted quinazolines as Tubulin Polymerization Promotors and Antiproliferative Agents
Ashish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Ashish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Discovery of a novel microtubule destabilizing agent targeting the colchicine site based on molecular docking
Jinhui Cai, Miao He, Yingying Wang, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116804-116804
Closed Access
Jinhui Cai, Miao He, Yingying Wang, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116804-116804
Closed Access
Aromatic nitroolefin with inhibition efficacy in triple-negative breast cancer cells by dual targeting RXRα and tubulins
Xian‐Jun Qu, Yanxia Wang, Yunqing Xu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117486-117486
Closed Access
Xian‐Jun Qu, Yanxia Wang, Yunqing Xu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117486-117486
Closed Access
Discovery of a novel 2,4‐thiazolidinedione derivative as dual inhibitor of β‐catenin/TCF4 interaction and tubulin polymerization in colon cancer cells
Yating Guo, Meng Cao, Zhaohui Li, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Yating Guo, Meng Cao, Zhaohui Li, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Targeted Polypeptide–Microtubule Aggregation with Cucurbit[8]uril for Enhanced Cell Apoptosis
Ying‐Ming Zhang, Jiang‐Hua Liu, Qilin Yu, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 31, pp. 10553-10557
Closed Access | Times Cited: 53
Ying‐Ming Zhang, Jiang‐Hua Liu, Qilin Yu, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 31, pp. 10553-10557
Closed Access | Times Cited: 53
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment
Angela Flavia Serpico, Roberta Visconti, Domenico Grieco
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 47
Angela Flavia Serpico, Roberta Visconti, Domenico Grieco
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 47
Intrinsic and Extrinsic Factors Affecting Microtubule Dynamics in Normal and Cancer Cells
Filip Borys, Ewa Joachimiak, H. Krawczyk, et al.
Molecules (2020) Vol. 25, Iss. 16, pp. 3705-3705
Open Access | Times Cited: 47
Filip Borys, Ewa Joachimiak, H. Krawczyk, et al.
Molecules (2020) Vol. 25, Iss. 16, pp. 3705-3705
Open Access | Times Cited: 47
Tubulin heterogeneity regulates functions and dynamics of microtubules and plays a role in the development of drug resistance in cancer
Shweta Shyam Prassanawar, Dulal Panda
Biochemical Journal (2019) Vol. 476, Iss. 9, pp. 1359-1376
Open Access | Times Cited: 44
Shweta Shyam Prassanawar, Dulal Panda
Biochemical Journal (2019) Vol. 476, Iss. 9, pp. 1359-1376
Open Access | Times Cited: 44
